Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Buprenorphine for the Management of Pain in Children With Sickle Cell Disease

NCT07799571 is registered in ClinicalTrials.gov with Natasha Archer as lead sponsor.

NCT NCT07799571
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07799571 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Buprenorphine for the Management of Pain in Children With Sickle Cell Disease
Lead sponsor
Natasha Archer
Phase
Phase 1
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
October 31, 2032
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain crisis, sickle cell anemia (hbss, or hbsβ-thalassemia0), sickle cell anemia crisis, sickle cell anemia in children, sickle cell disease (scd), sickle cell disease vaso-occlusive crisis, sickle cell hemoglobin c disease